ES2611984T3 - Preparaciones cosméticas que contienen fragmentos de PTH - Google Patents

Preparaciones cosméticas que contienen fragmentos de PTH Download PDF

Info

Publication number
ES2611984T3
ES2611984T3 ES05758418.7T ES05758418T ES2611984T3 ES 2611984 T3 ES2611984 T3 ES 2611984T3 ES 05758418 T ES05758418 T ES 05758418T ES 2611984 T3 ES2611984 T3 ES 2611984T3
Authority
ES
Spain
Prior art keywords
oil
acid
increase
preparations containing
cosmetic preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05758418.7T
Other languages
English (en)
Spanish (es)
Inventor
Philippe Moussou
Louis Danoux
Vincent Bardey
Christine Jeanmaire
Gilles Pauly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
BASF Beauty Care Solutions France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Beauty Care Solutions France SAS filed Critical BASF Beauty Care Solutions France SAS
Application granted granted Critical
Publication of ES2611984T3 publication Critical patent/ES2611984T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
ES05758418.7T 2004-06-14 2005-06-06 Preparaciones cosméticas que contienen fragmentos de PTH Expired - Lifetime ES2611984T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04291496 2004-06-14
EP04291496 2004-06-14
PCT/EP2005/006261 WO2005120554A1 (en) 2004-06-14 2005-06-06 Cosmetic preparations containing pth fragments

Publications (1)

Publication Number Publication Date
ES2611984T3 true ES2611984T3 (es) 2017-05-11

Family

ID=34971962

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05758418.7T Expired - Lifetime ES2611984T3 (es) 2004-06-14 2005-06-06 Preparaciones cosméticas que contienen fragmentos de PTH

Country Status (6)

Country Link
US (1) US9387235B2 (cg-RX-API-DMAC7.html)
EP (1) EP1755651B1 (cg-RX-API-DMAC7.html)
JP (1) JP5324781B2 (cg-RX-API-DMAC7.html)
KR (1) KR101240695B1 (cg-RX-API-DMAC7.html)
ES (1) ES2611984T3 (cg-RX-API-DMAC7.html)
WO (1) WO2005120554A1 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101594032B1 (ko) 2012-08-23 2016-02-15 강원대학교산학협력단 염증 또는 피부노화의 예방 또는 치료용 약학 조성물 및 염증 또는 피부노화 개선용 화장료 조성물
WO2016105607A1 (en) * 2014-12-23 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
FR3049859B1 (fr) 2016-04-12 2023-11-03 Basf Beauty Care Solutions France Sas Utilisation cosmetique d'un extrait de khaya senegalensis
FR3055799B1 (fr) 2016-09-15 2020-06-19 Basf Beauty Care Solutions France Sas Nouvelle utilisation cosmetique et/ou nutraceutique ou dermatologique d'un extrait de levure
FR3058641B1 (fr) 2016-11-17 2019-11-01 Basf Beauty Care Solutions France Sas Utilisation cosmetique, nutraceutique ou pharmaceutique preferentiellement dermatologique d'un extrait de feuilles de la plante lansium domesticum pour diminuer la pigmentation de la peau et/ou des annexes cutanees
FR3061015B1 (fr) 2016-12-23 2019-09-20 Basf Beauty Care Solutions France Sas Utilisation cosmetique d'un extrait de corchorus olitorius
KR102007078B1 (ko) * 2017-03-24 2019-08-05 (주)셀아이콘랩 콜라겐 생성을 촉진시키는 신규한 헵타펩타이드 단량체 및 이량체를 포함하는 피부 노화 방지를 위한 화장품 조성물
KR102007077B1 (ko) * 2017-03-24 2019-08-06 (주)셀아이콘랩 피부 노화 방지 및 피부 주름 예방용 펜타펩타이드와 펜타펩타이드 다이머의 제조방법과 이를 포함하는 화장료 조성물
KR101989666B1 (ko) * 2017-03-24 2019-06-17 (주)셀아이콘랩 신규한 헵타펩타이드 단량체 및 이량체를 포함하는 피부노화 또는 피부주름 예방, 개선을 위한 화장료 조성물
KR102007079B1 (ko) * 2017-03-24 2019-10-02 (주)셀아이콘랩 펩타이드를 활용한 피부의 노화 억제용 조성물 및 세포노화 억제와 주름개선을 위한 화장품 조성물
FR3065876B1 (fr) 2017-05-05 2020-08-14 Basf Beauty Care Solutions France Sas Utilisation d'un extrait de nephelium lappaceum pour augmenter la fermete de la peau et/ou des muqueuses
FR3069162A1 (fr) 2017-07-24 2019-01-25 Basf Beauty Care Solutions France Sas Extrait aqueux de momordica cochinchinensis pour maintenir et/ou augmenter l'expression des kindlines de la peau et des muqueuses
FR3097127B1 (fr) 2017-10-03 2022-09-16 Basf Beauty Care Solutions France Sas Procédé d’utilisation d’un inhibiteur de Let-7b en cosmétique et/ou en nutraceutique
FR3071742B1 (fr) 2017-10-03 2020-07-10 Basf Beauty Care Solutions France Sas Procede d'utilisation d'un inhibiteur de let-7b en cosmetique et/ou en nutraceutique
US11975050B2 (en) * 2018-03-16 2024-05-07 The General Hospital Corporation Parathyroid hormone polypeptide conjugates and methods of their use
WO2020183318A1 (en) * 2019-03-08 2020-09-17 Anya Biopharm Inc. Oral formulation and treatment of pth analog.
CN114736265A (zh) * 2022-04-20 2022-07-12 广州市乾相生物科技有限公司 一种四肽-9的合成方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172887A (en) 1973-11-30 1979-10-30 L'oreal Hair conditioning compositions containing crosslinked polyaminopolyamides
LU68901A1 (cg-RX-API-DMAC7.html) 1973-11-30 1975-08-20
GB8806893D0 (en) 1988-03-23 1988-04-27 Unilever Plc Cosmetic composition
JPH06239815A (ja) * 1993-02-16 1994-08-30 Teijin Ltd 2―アミノエトキシベンゼン誘導体及び医薬組成物
US6110892A (en) * 1994-06-20 2000-08-29 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US5744128A (en) * 1995-05-03 1998-04-28 Holick; Michael F. Use of emu oil for stimulating skin and hair growth
FR2738746B1 (fr) 1995-09-19 1997-11-14 Oreal Utilisation d'au moins un peptide dans une composition cosmetique ou pour la preparation d'un medicament
DE19756377A1 (de) 1997-12-18 1999-06-24 Beiersdorf Ag Verwendung von C¶1¶¶8¶-¶3¶¶8¶-Alkylhydroxystearoylstearat zur Verstärkung der UV-A-Schutzleistung kosmetischer oder dermatologischer Formulierungen
FR2781157B1 (fr) 1998-07-15 2000-08-25 Oreal Composition anti-inflammatoire
FR2781231B1 (fr) 1998-07-17 2002-01-25 Sederma Sa Compositions cosmetiques amincissantes
FR2788058B1 (fr) 1998-12-30 2002-01-25 Sederma Sa Compositions cosmetiques amincissantes
US6890904B1 (en) * 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
JP2001287013A (ja) 2000-04-10 2001-10-16 Yazaki Corp ダイカスト鋳造における湯流れ確認方法
US6756480B2 (en) * 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
JP2004536018A (ja) * 2000-07-31 2004-12-02 バル・イラン・ユニバーシティ 創傷治療のための方法および薬学的組成物
FR2827170B1 (fr) * 2001-07-13 2004-07-16 Soc Extraction Principes Actif Utilisation de peptides pour augmenter l'adhesion cellulaire
JP2003300823A (ja) 2002-04-09 2003-10-21 Nonogawa Shoji Kk 皮膚外用剤
JP4196605B2 (ja) 2002-07-29 2008-12-17 王子製紙株式会社 コラーゲン産生促進剤
AU2002951372A0 (en) 2002-09-13 2002-09-26 St Vincent's Institute Of Medical Research Parathyroid hormone-like polypeptides
JP2009124502A (ja) 2007-11-15 2009-06-04 Toshiba Corp フレーム補間装置

Also Published As

Publication number Publication date
JP2008502624A (ja) 2008-01-31
EP1755651B1 (en) 2016-10-12
EP1755651A1 (en) 2007-02-28
US9387235B2 (en) 2016-07-12
US20110059892A1 (en) 2011-03-10
JP5324781B2 (ja) 2013-10-23
KR20070018120A (ko) 2007-02-13
WO2005120554A1 (en) 2005-12-22
KR101240695B1 (ko) 2013-03-11

Similar Documents

Publication Publication Date Title
JP7564568B2 (ja) 皮膚用組成物
CN102149366A (zh) 美白剂、抗老化剂以及皮肤化妆品
ASAKAWA Biologically active compounds from bryophytes
Cao et al. Adipose-derived mesenchymal stem cells are ideal for the cell-based treatment of refractory wounds: strong potential for angiogenesis
JP2018150262A (ja) 抗老化剤
JP5889546B2 (ja) ヘキソサミニダーゼ遊離抑制剤、幹細胞増殖因子mRNA発現上昇抑制剤、過酸化水素細胞障害の予防・改善剤及びグルタチオン産生促進剤
US20200164014A1 (en) Mesenchymal stem cell attracting agent
Jalali et al. Transplanted Wharton’s jelly mesenchymal stem cells improve memory and brain hippocampal electrophysiology in rat model of Parkinson’s disease
JP6449216B2 (ja) ソリダゴ・ウィルガウレア亜種アルペストリス(Solidago virgaurea subsp. alpestris)の地上部のアルコール抽出物、その生産方法、およびそれを含む化粧用または皮膚科用組成物
Moradi et al. Osteogenic differentiation of human amniotic mesenchymal stem cells by phycocyanin and phycoerythrin pigments isolated from Spirulina platensis and Gracilaria gracilis algae
JP5566733B2 (ja) エンドセリン−1mRNA発現、幹細胞増殖因子(SCF)mRNA発現抑制剤、塩基性線維芽細胞増殖因子(bFGF)mRNA発現抑制剤、グルタチオン産生促進剤、及びフィラグリン産生促進剤
KR20160086649A (ko) 케라틴과 egcg 복합체를 함유하는 조성물 및 그 제조방법
US20090306219A1 (en) Topical use of plant extract for skin detoxification
JP2009235044A (ja) エンドセリン−1mRNA発現抑制剤、マトリックスメタロプロテアーゼ−9mRNA発現抑制剤、コラーゲン産生促進剤、プロフィラグリン産生促進剤、フィラグリン産生促進剤及びアクアポリン3mRNA発現促進剤
KR20190130035A (ko) 유기 화합물에서의 또는 이와 관련된 개선
JP2013155122A (ja) 幹細胞賦活化剤
JP2011074022A (ja) 幹細胞増殖因子(SCF)mRNA発現促進剤
JP2011115152A (ja) スクリーニング法
JP5566597B2 (ja) I型コラーゲン産生促進剤、アデノシン三リン酸産生促進剤、フィラグリン産生促進剤、メラニン産生抑制剤、塩基性線維芽細胞増殖因子(bFGF)mRNA発現抑制剤、及び肌の透明感向上剤
US12357559B2 (en) Cosmetic composition for preventing skin aging and reducing skin wrinkles, comprising Viburnum stellato-tomentosum extract
JP2002284648A (ja) 育毛剤組成物
KR20230172226A (ko) 라벤더잎세포추출물을 유효성분으로 포함하는 외부 자극에 의한 피부 장벽개선 및 피부 진정(붉은기)에 효과적인 조성물
JP2008088075A (ja) プロフィラグリン/フィラグリン産生促進剤、表皮角化細胞増殖促進剤、表皮/角層正常化用皮膚外用剤、プロフィラグリン及び/又はフィラグリン産生促進方法、及び表皮角化細胞増殖促進方法
JP2023020931A (ja) Tsg-6の発現向上作用を指標とするスクリーニング方法及びtsg-6の発現向上用組成物
KR20230146505A (ko) 육모제